Ohio Public Employees Retirement System (OPERS)’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.5K Sell
1,703
-146
-8% -$2K ﹤0.01% 2118
2026
Q1
$23K Sell
1,849
-147
-7% -$1.97K ﹤0.01% 2161
2025
Q4
$25.1K Sell
1,996
-462
-19% -$5.29K ﹤0.01% 2152
2025
Q3
$24.6K Sell
2,458
-70
-3% -$628 ﹤0.01% 2141
2025
Q2
$20.5K Sell
2,528
-163
-6% -$1.23K ﹤0.01% 2185
2025
Q1
$22.6K Buy
+2,691
New +$22.5K ﹤0.01% 2141
2024
Q3
– Sell
-24,510
Closed -$156K – 2215
2024
Q2
$156K Sell
24,510
-1,483
-6% -$9.41K ﹤0.01% 1390
2024
Q1
$158K Sell
25,993
-1,122
-4% -$6.33K ﹤0.01% 1379
2023
Q4
$165K Sell
27,115
-10,685
-28% -$47.6K ﹤0.01% 1400
2023
Q3
$160K Buy
+37,800
New +$141K ﹤0.01% 1387

Other funds holding AMRX

Ohio Public Employees Retirement System (OPERS)'s AMRX Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) reduced its Amneal Pharmaceuticals (AMRX) stake by 7.9% in Q2 2026, selling an estimated $2K and leaving 1,703 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2118.

Ohio Public Employees Retirement System (OPERS) first reported a position in AMRX in Q3 2023 and has held it in 10 quarters since. The position peaked at $165K in Q4 2023. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) held 1,703 shares of Amneal Pharmaceuticals worth $29.5K as of Q2 2026.
  • Ohio Public Employees Retirement System (OPERS) sold 146 Amneal Pharmaceuticals shares in Q2 2026, an estimated $2K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #2118 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Amneal Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Amneal Pharmaceuticals position peaked at $165K in Q4 2023.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.